Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-05

Clinical Trial Update: A Prospective Study to Evaluate miRNA371 and Outcomes in Patients With Newly Diagnosed Germ Cell Tumors

View source ↗

Summary

A prospective study to evaluate miRNA-371 as a biomarker and collect outcomes in patients with newly diagnosed germ cell tumors, focusing on testicular germ cel…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Fondazione del Piemonte per l'Oncologia | Conditions: Testicular Germ Cell Tumor | Status: RECRUITING